Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study.
Journal: Diabetes spectrum : a publication of the American Diabetes Association
Published: August 16, 2023
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study.
Journal: Diabetes, obesity & metabolism
Published: October 28, 2022
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: March 24, 2021
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2.
Journal: Diabetes, obesity & metabolism
Published: April 15, 2020
Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes.
Journal: Postgraduate medicine
Published: October 04, 2019
The MARLINA-T2D trial: putting the results into clinical perspective.
Journal: Expert review of endocrinology & metabolism
Published: July 31, 2018
The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.
Journal: Current medical research and opinion
Published: March 10, 2017
The Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk.
Journal: Drugs - real world outcomes
Published: July 12, 2016
CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: February 12, 2016
Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 01, 2015
The potential role of sodium glucose co-transporter 2 inhibitors in combination therapy for type 2 diabetes mellitus.
Journal: Expert opinion on pharmacotherapy
Published: October 16, 2014
Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
Journal: Clinical therapeutics
Published: February 05, 2014
Last Updated: 09/26/2026